It is a healthcare private limited company based in New Delhi, Delhi, India, established in 1994.
1994 | New Delhi, Delhi, India | ActiveShree Shodashi Therapeutics Private Limited, a active private limited company, was established on 19 May 1994 in New Delhi, Delhi, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U85110DL1994PTC059119. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.20 M and a paid-up capital of ₹3.19 M.
Formerly known as Eps Securities Limited, Welcure Health Limited. It upholds a compliant status. Its leadership includes Nimisha Gupta (Director), Murari Lal Gupta (Additional Director). Past directors included Apar Jindal, Mohit Gupta, Raj Kumar Jain. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at M-14, Balram House, Karampura Commercial Complex,, New Delhi, Delhi, 110015.
U85110DL1994PTC059119
059119
19 May 1994
₹3.20 M
₹3.19 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Shree Shodashi Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nimisha Gupta | Director | 21 Feb 2011 | Current |
| Murari Lal Gupta | Additional Director | 16 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Sep 2022 | Past |
| Pramod Abcsdd | Director | 17 Jul 2025 | Past |
| Pramod Abcsdd | Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 22 Feb 2011 | Past |
| Pramod Abcsdd | Director | 22 Feb 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Welcure Health Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 900% increase. The company also saw a substantial improvement in profitability, with a 3679.56% increase in profit. The company's net worth moved up by a moderate rise of 6.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Shree Shodashi Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shree Shodashi Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shree Shodashi Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Shodashi Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shree Shodashi Therapeutics Private Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was completed.
Murari Lal Gupta was appointed as a Additional Director was appointed as a Additional Director on 16 Jul 2025 & has been associated with this company since 5 months . was recorded as a recent event.
Shree Shodashi Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on Nimisha Gupta was appointed as a Director was appointed as a Director on 21 Feb 2011 & has been associated with this company since 14 years 9 months . was documented.
The activity Shree Shodashi Therapeutics Private Limited was registered on 19 May 1994 with Roc Delhi & aged 31 years 6 months as per MCA records. was completed.
The CIN of Shree Shodashi Therapeutics Private Limited is U85110DL1994PTC059119.
Shree Shodashi Therapeutics Private Limited is headquartered at M-14, Balram House, Karampura Commercial Complex,, New Delhi, Delhi, 110015.
Shree Shodashi Therapeutics Private Limited was incorporated on 19 May 1994.
The current directors of Shree Shodashi Therapeutics Private Limited are
The primary industry of Shree Shodashi Therapeutics Private Limited is Hospital And Medical Care.
Shree Shodashi Therapeutics Private Limited is unlisted.
The authorized capital of Shree Shodashi Therapeutics Private Limited is ₹3.20 M, and the paid-up capital is ₹3.19 M.
The compliance status of Shree Shodashi Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX